cis-2-Phenoxy-N-((3-phenyl-1,4-dioxan-2-yl)methyl)ethanamine

ID: ALA4580139

PubChem CID: 155565707

Max Phase: Preclinical

Molecular Formula: C19H23NO3

Molecular Weight: 313.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccc(OCCNC[C@H]2OCCO[C@H]2c2ccccc2)cc1

Standard InChI:  InChI=1S/C19H23NO3/c1-3-7-16(8-4-1)19-18(22-13-14-23-19)15-20-11-12-21-17-9-5-2-6-10-17/h1-10,18-20H,11-15H2/t18-,19+/m1/s1

Standard InChI Key:  ZVHRVSHMCKYIMH-MOPGFXCFSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   39.0436  -10.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0436   -9.4761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7530  -10.7060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.4583  -10.2974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4583   -9.4761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7530   -9.0634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.1695  -10.7112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8819  -10.2995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.5932  -10.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3056  -10.3015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0168  -10.7153    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   44.7293  -10.3036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4329  -10.7214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1449  -10.3104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.1465   -9.4882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.4303   -9.0787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7254   -9.4880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1677   -9.0717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8786   -9.4840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5911   -9.0782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5940   -8.2560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8784   -7.8414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1687   -8.2537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  6  1  0
  1  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  1
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  5 18  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4580139

    ---

Associated Targets(Human)

ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 313.40Molecular Weight (Monoisotopic): 313.1678AlogP: 2.81#Rotatable Bonds: 7
Polar Surface Area: 39.72Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.95CX LogP: 3.03CX LogD: 1.48
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.80Np Likeness Score: -0.10

References

1. Del Bello F, Bonifazi A, Giorgioni G, Quaglia W, Amantini C, Morelli MB, Santoni G, Battiti FO, Vistoli G, Cilia A, Piergentili A..  (2019)  Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells.,  168  [PMID:30844609] [10.1016/j.ejmech.2019.02.056]

Source